Health knowledge made personal
Join this community!
› Share page:
Search posts:

Continuous disease-modifying treatment without interruptions provides better long-term outcomes in MS

Posted Jun 30 2009 4:45pm
People with MS who adhere to their treatment with interferon (IFN) beta-1a without interruption have lower relapse and progression rates than people who do not not, said researchers here at the 19th Meeting of the European Neurological Society.

To read more, as reported by the UK MS Trust: click here.

Source: UK MS Trust

Post a comment
Write a comment:

Related Searches